Gesundheit: A steady consumer market and rising physician visits have supported the industry
Abstract
Allergy Medicine Manufacturing OTC As healthcare coverage has expanded and health expenditure has grown over the five years to 2019, demand for over-the-counter (OTC) allergy medicine has steadily increased. Given the necessity of allergy medicine for people with allergies, demand for industry products has remained strong. As a result, over the five years to 2019, Allergy Medicine Manufacturing OTC industry revenue is expected to have grown in line with healthcare coverage and physician visits. Over the next five years, demand for OTC allergy medicine is likely to continue growing. Barring any significant policy changes, health insurance coverage is expected to remain relatively steady over the next five years, so people will continue getting allergy medicine recommendations from physicians.
This industry manufactures over-the-counter (OTC) allergy medication, including brand name and generic products. Products include antihistamines and decongestants.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Our reports have been used by over 10K customers, including:
122 pages •
By Euromonitor International
• Nov 2020
The outbreak of COVID-19 in South Korea is not predicted to increase growth in 2020, with value growth of 3% expected for the year, compared to value growth of 5% recorded in 2019. As South Korea did not have an enforced lockdown, sales were not impacted by high levels of stockpiling that was seen in other countries Consumer Health...
106 pages •
By Euromonitor International
• Nov 2020
Consumer health value sales will continue to grow in 2020, despite the negative economic impact of COVID-19 on the economy. Lower purchasing power among middle-income consumers and the rising cost of healthcare in Argentina have fuelled a shift towards self-medication in recent years, thus encouraging preventive healthcare. Following this...
Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Conjunctivitis Clinical trials scenario. This report provides top line data relating to the clinical trials on...
Allergic Rhinitis Drugs Market Research Report by Route of Administration (Intranasal, Oral, and Parenteral), by Class of Drugs (Antihistamines, Immunotherapies, and Intranasal Corticosteroids), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides market...
122 pages •
By Euromonitor International
• Oct 2020
The outbreak of Coronavirus (COVID-19) and the subsequent lockdown have had a strong effect on consumer health in Belgium. Thus, there have been significant switches from category to category, as well as one distribution channel to another due to strong restrictions on retailing. Consumer Health in Belgium report offers a comprehensive...
122 pages •
By Euromonitor International
• Nov 2020
Following the emergence of COVID-19 in Greece and the announcement of lockdown measures in March in a bid to control the spread of the virus, consumers took to stockpiling basic medicines such as acetaminophen, various cough and cold remedies including nasal sprays and pharyngeal preparations to equip themselves against various symptoms, in...
113 pages •
By Euromonitor International
• Nov 2020
To mitigate the risk of contracting COVID-19 consumers in Japan have been confining themselves to their homes on a more regular basis, while they are also taking a more proactive approach to their health, focusing on prevention over treatment. This has resulted in contrasting fortunes for the various product categories within consumer health....
102 pages •
By Euromonitor International
• Nov 2020
COVID-19 resulted in increased consumer interest in prevention and self-treatment in Taiwan in 2020. The systemic analgesics and cold and cough remedies categories demonstrated higher growth in 2020 than the previous year as a result. This was further underpinned by consumers’ reluctance to visit hospitals or clinics during the pandemic, in...